ES535471A0 - Procedimiento de un nuevo peptido como agente de proteccion contra el colera y-0 las gastroenteritis infecciosas. - Google Patents

Procedimiento de un nuevo peptido como agente de proteccion contra el colera y-0 las gastroenteritis infecciosas.

Info

Publication number
ES535471A0
ES535471A0 ES535471A ES535471A ES535471A0 ES 535471 A0 ES535471 A0 ES 535471A0 ES 535471 A ES535471 A ES 535471A ES 535471 A ES535471 A ES 535471A ES 535471 A0 ES535471 A0 ES 535471A0
Authority
ES
Spain
Prior art keywords
peptide
amino acids
cholera
agent
chain
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES535471A
Other languages
English (en)
Other versions
ES8608046A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institut Pasteur de Lille
Original Assignee
Institut Pasteur de Lille
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Institut Pasteur de Lille filed Critical Institut Pasteur de Lille
Publication of ES8608046A1 publication Critical patent/ES8608046A1/es
Publication of ES535471A0 publication Critical patent/ES535471A0/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/28—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Vibrionaceae (F)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • C07K14/245—Escherichia (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/832—Drug, bio-affecting and body treating compositions involving bacterial toxin that has modified amino acid sequence
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/81—Packaged device or kit
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/975—Kit

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
ES535471A 1983-08-29 1984-08-28 Procedimiento de un nuevo peptido como agente de proteccion contra el colera y-0 las gastroenteritis infecciosas. Expired ES8608046A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8313828A FR2551088B1 (es) 1983-08-29 1983-08-29

Publications (2)

Publication Number Publication Date
ES8608046A1 ES8608046A1 (es) 1986-06-16
ES535471A0 true ES535471A0 (es) 1986-06-16

Family

ID=9291849

Family Applications (1)

Application Number Title Priority Date Filing Date
ES535471A Expired ES8608046A1 (es) 1983-08-29 1984-08-28 Procedimiento de un nuevo peptido como agente de proteccion contra el colera y-0 las gastroenteritis infecciosas.

Country Status (10)

Country Link
US (2) US4686281A (es)
EP (1) EP0139555B1 (es)
JP (1) JPS60155195A (es)
AT (1) ATE24918T1 (es)
DE (1) DE3462040D1 (es)
ES (1) ES8608046A1 (es)
FR (1) FR2551088B1 (es)
GR (1) GR80230B (es)
MA (1) MA20214A1 (es)
OA (1) OA07802A (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3712890A1 (de) * 1987-04-15 1988-10-27 Teichmann Reinhard K Priv Doz Verwendung antigener substanzen zur prophylaxe oder therapie von stoerungen und krankheiten im verdauungstrakt von tieren und menschen
US6673355B1 (en) 1995-06-14 2004-01-06 Baylor College Of Medicine Rotavirus enterotoxin NSP4 and methods of using same
EP0833670B1 (en) * 1995-06-14 2003-09-03 Baylor College Of Medicine Vaccine against rotavirus infection comprising peptides of viral enterotoxin nsp4

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2825619A1 (de) * 1977-06-22 1979-01-11 Sandoz Ag Vakzinen gegen ferkel-colibacillose und verfahren zu ihrer herstellung
DE2919592A1 (de) * 1979-05-15 1981-01-15 Max Planck Gesellschaft Verfahren zur herstellung von thymosin- alpha 1 und derivaten davon
EP0040149B1 (en) * 1980-05-12 1984-05-09 Choay S.A. Oligopeptides with specific inhibiting properties of collagen induced aggregation, process for preparing the same and pharmaceutical compositions containing them
US4520016A (en) * 1980-06-17 1985-05-28 Kabigen Ab Bacteriolytic proteins
DE3117934A1 (de) * 1981-05-06 1982-12-09 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V., 3400 Göttingen Neues peptid, verfahren zu seiner gewinnung und dieses enthaltendes arzneimittel
US4415558A (en) * 1981-06-08 1983-11-15 The Salk Institute For Biological Studies CRF And analogs
NL8102856A (nl) * 1981-06-15 1983-01-03 Unilever Nv Werkwijze ter bereiding van bloedceleiwit en haem uit haemoglobine.
US4392997A (en) * 1981-07-06 1983-07-12 Northwestern University Antigenic peptide compounds
FR2525592B1 (es) * 1982-04-26 1984-09-14 Pasteur Institut
ZA838780B (en) * 1982-11-26 1985-01-30 Nyegaard & Co As Peptide compounds
US4410514A (en) * 1982-12-06 1983-10-18 The Salk Institute For Biological Studies GnRH Agonists
US4504414A (en) * 1983-03-28 1985-03-12 Board Of Regents, The University Of Texas System Synthetic pyridyl-alanyl decapeptides having antiovulatory activity
US4504415A (en) * 1983-04-04 1985-03-12 Hoffman-La Roche Inc. Synthesis of thymosin α1 and desacetyl thymosin α1
US4478827A (en) * 1983-05-09 1984-10-23 The General Hospital Corporation Renin inhibitors
US4515920A (en) * 1984-04-30 1985-05-07 The Rockefeller University Synthesis of peptides and proteins

Also Published As

Publication number Publication date
ES8608046A1 (es) 1986-06-16
US4898815A (en) 1990-02-06
US4686281A (en) 1987-08-11
FR2551088A1 (es) 1985-03-01
EP0139555B1 (fr) 1987-01-14
GR80230B (en) 1985-01-02
OA07802A (fr) 1986-11-20
DE3462040D1 (en) 1987-02-19
JPS60155195A (ja) 1985-08-15
ATE24918T1 (de) 1987-01-15
EP0139555A1 (fr) 1985-05-02
FR2551088B1 (es) 1985-12-06
MA20214A1 (fr) 1985-04-01

Similar Documents

Publication Publication Date Title
DE3683528D1 (de) Tetrapyrrol-therapiemittel.
DK326785A (da) Terapeutisk middel til paavisning og/eller behandling af tumorer og fremgangsmaade til fremstilling af et saadant middel
ATE31625T1 (de) Pharmazeutisches mittel zur behandlung des diabetes mellitus.
ES8609303A1 (es) Un procedimiento para la preparacion de un derivado de acido6-fluor-1,4-dihidro-4-oxo-7-piperazinilquinolin sustituido-3-carboxilico
EA199900621A1 (ru) Лечение рассеянного склероза путем приема внутрь или ингаляции сополимера-1
RU94016354A (ru) Новые полипептидные соединения, способ их получения, фармацевтическая композиция, способ лечения
ES2071815T3 (es) Analogos de delecion de los peptidos conocidos como magaininas.
IL132933A0 (en) Composition for the treatment of diarrheal disease
DK0805685T3 (da) Hidtil ukendte antifungale cyclohexapeptider
EA200300882A1 (ru) Способ лечения демиелинизирующих заболеваний или состояний
NO180334C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive difluorstatonanaloger
DE3667059D1 (en) Benzodipyrroles, processes for their preparation and pharmaceutical compositions containing these compounds
HUT55034A (en) Process for producing peptides with hemoregulating effect and pharmaceutical compositions comprising such compounds as active ingredient
DK204686D0 (da) Quinolylglycinamidderivater og fremgangsmaade til fremstilling deraf
DE69518164D1 (de) Verfahren zur herstellung von n-(amidinophenyl pyrrolidin)-n'-beta-alanin-substituierten harnstoffen
ES535471A0 (es) Procedimiento de un nuevo peptido como agente de proteccion contra el colera y-0 las gastroenteritis infecciosas.
MY112944A (en) Enterokinetic benzamide
DE69330268D1 (de) Hämoregulierende peptide
ATE195954T1 (de) Antibiotisches cryptdinpeptid und anwendungsmethoden
ATE86260T1 (de) Peptid-molekuele, wirksam gegen gram-positive keime.
ME00379B (me) Memno peptidi, postupak za njihovo pripremanje i njihova primjena
BR9604843A (pt) Peptìdeo e derivado do mesmo, e, droga e composição para tratar osteopatia
KR910018553A (ko) 박테리오신 펩티드 (bacteriocin peptide)
DE69208591D1 (de) Verfahren zur Herstellung von 1R, cis 2,2,-Dimethyl-3-Formyl-Cyclopropan-1-Carbonsäurelacton und halogenierten Zwischenverbindungen
UA6882C2 (uk) Стерилізуючий засіб

Legal Events

Date Code Title Description
MM4A Patent lapsed

Effective date: 19960506